Ojjaara (Momelotinib)
- Medicine Name: Ojjaara
- API: Momelotinib
- Dosage Form & Strength: Tablets: 100 mg, 150 mg, 200 mg
- Manufactured By: GlaxoSmithKline
Ojjaara (momelotinib) is a kinase inhibitor used for the treatment of intermediate or high-risk myelofibrosis (MF), including primary MF or secondary MF [postpolycythemia vera (PV) and post-essential thrombocythemia (ET)], in adults with anemia.
Recommended Dosage: The recommended dosage of Ojjaara is 200 mg orally once daily with or without food. Swallow tablets whole (don’t crush, cut, or chew). In case of a missed dose of Momelotinib, skip the missed dose and take the very next dose the following day at your regular time. Avoid taking 2 doses at the same time to make up for the missed dose.
- Serious (including fatal) infections (e.g., bacterial and viral, including COVID-19) may occur in patients treated with Ojjaara 100 mg/150 mg/200 mg. Delay starting treatment until active infections have resolved. Monitor patients receiving this medicine for signs and symptoms of infection and start suitable therapy promptly.
- Momelotinib can cause thrombocytopenia and neutropenia. Assess complete blood counts (CBC), including platelet and neutrophil counts, before starting therapy and periodically during therapy as clinically indicated. Interrupt dosing or reduce the dose for thrombocytopenia or neutropenia.
- New or worsening elevations of ALT and AST (all grades) may occur in patients treated with this medicine. Monitor liver tests at baseline, every month for six months during treatment, then periodically as clinically required. If increases in ALT, AST, or bilirubin related to treatment are suspected, modify dosage.
- Momelotinib may harm your unborn baby. Females who can become pregnant should use effective birth control (contraception) during treatment and for 1 week after the last dose of Momelotinib. Tell your doctor right away if you think you are pregnant or become pregnant during treatment with Momelotinib.
What documents are required to import OJJAARA to India?
OJJAARA (momelotinib) tablets can be imported by patients or government hospitals on the name of the patients only.
The following documentation is required to import the product:
- A valid prescription from a qualified doctor.
- Patients diagnostic reports
- Patients ID proof (issued by the government of India)
The order will be confirmed only after the receipt of:
- A valid prescription from Doctor
- Import permit if applicable
OJJAARA (momelotinib tablets) is a (prescription drug, prescription medication, or prescription medicine) pharmaceutical drug that legally requires a medical prescription to be dispensed.
IPN (Indian Pharma Network) helps import cancer medicines on the named patient supply (NPS). Indian Pharma Network is the facilitator providing input
- On availability of Ojjaara in India (Mumbai, Kolkata, Hyderabad, Chennai, Ahmedabad, Delhi, Bangalore, Pune etc.)
- Medicine Price.
- Finding Genuine and reliable sources from the USA, Canada, Europe, and Australia
- Ensuring 100% transparency.
IPN (Indian Pharma Network) can facilitate the supply of OJJAARA (prescription medicines) to all locations in the world and in India after fulfilling the legal requirement (if applicable).
Please contact +91-9310090915 | Toll-Free Number: 1800-889-1064 or write us at info@indianpharmanetwork.in for Ojjaara 100 mg/150 mg/200 mg price in India.
We take to guarantee quality and delivery anywhere in the world as per the buyer
What is the Generic Name for the trade name drug Ojjaara®?
Momelotinib is a Generic Name for the trade name drug Ojjaara®.
What is the Manufacturer’s Name of Ojjaara®?
Ojjaara® is manufactured by GlaxoSmithKline.
Is Ojjaara® approved by the FDA?
Yes, Ojjaara® is approved by the FDA. Date of first approval: September 15, 2023.
Where can I get Ojjaara® at the best price in India?
To get the best Ojjaara price in India, kindly contact the Indian Pharma Network (a WHO GDP and ISO 9001:2008 certified company). For Ojjaara®, a medical prescription is needed from a treating physician.
What is the dosage and form of Ojjaara® supplied?
Ojjaara® is supplied as Tablets: 100 mg, 150 mg, and 200 mg for oral administration.
What are the most common side effects of Ojjaara®?
The most common side effects of Ojjaara® are bacterial infection, thrombocytopenia, hemorrhage, diarrhea, fatigue, dizziness, and nausea.
How much does Ojjaara® cost in India?
The cost of Ojjaara in India can vary. To procure this medication legally, you can call or WhatsApp +91-9310090915 or send mail to info@indianpharmanetwork.in.
What are the storage conditions of Ojjaara®?
Store the tablets of Ojjaara® at 20 to 25°C (68 to 77°F); excursions permitted to 15 to 30°C (59 to 86°F).
Is it safe to buy Ojjaara® online in India?
Yes, one can buy Ojjaara online in India at the lowest price from the Indian Pharma Network (IPN) if this medicinal product is not (yet) registered or available in their country. We can help facilitate the supply of Ojjaara® through legal channels.
Contact Patient Support
If you have any questions or need any help, contact our Patient Support Team. We will get in touch with you within 24 hours from Monday to Friday between 9:00 and 10:00 CET.
Disclaimer
All Trademarks and Brands that appear on the website belong to their respective owners and indianpharmanetwork does not lay any claim on them we only provide Information.